The Acessa System uses ultrasound-guided radiofrequency volumetric thermal ablation, which has been used in many other medical specialties such as cardiovascular surgery, orthopedics, general surgery, and neurosurgery because of the life-improving treatment effects. This study suggests that in fibroid treatment benefits can be found as well.
Low Re-intervention Rate – Treatment of Fibroids
Using the Acessa System for fibroid treatment, as mentioned, there was no need for further fibroid treatment in the year these patients were followed after treatment. During this time, the only reported adverse events were mild abdominal pain, not requiring treatment. Of the seven patients who had adverse reactions immediately following the procedure, four were due to abdominal pain, three in the umbilical area, and were effectively treated. Two were related to urinary tract infections, and in one patient, an abdominal wall vascular injury was discovered, but was resolved.
Significant Improvement in Quality of Life after Treatment of Fibroids
Quality of life by six months had improved from baseline to 80%. Symptom severity had also improved by 66% at six months. Reports of very heavy menstrual bleeding at baseline was 80%, and by six months had reduced
to 13%, and by twelve months no patients reported heavy or very heavy menses. Duration of menses also decreased from a baseline of 51% having menses lasting longer than six days to 13% at six months and 10% at 12 months. The study also reports a significant reduction in the rate of pad use by patients being over 15 per day at baseline at 66% to 20% at six months and only 5% at 12 months.
In conclusion, laparoscopic ultrasound-guided thermal ablation for fibroid treatment using the Acessa System significantly reduces symptoms, need for additional fibroid treatment, and improves patient quality of life significantly to at least 1 year after treatment.